SCHEMBL15901979

SCHEMBL15901979

Cc1c(I)cc(O)cc1I

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
TTR P02766 2/20 0.43
BACE1 P56817 1/20 0.41
CYP3A4 P08684 4/20 0.39
CHRM1 P11229 1/20 0.39
ALOX15 P16050 1/20 0.39
MAOA P21397 1/20 0.39
TBXA2R P21731 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR2B P41595 1/20 0.39
ACHE P22303 4/20 0.36
ALB P02768 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.32
HCAR1 Q9BXC0 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71182 0.80 TTR (0.65) ALDH1A1TTRBACE1CYP3A4CHRM1
SCHEMBL23907108 0.77 TTR (0.52) ALDH1A1TTRBACE1CYP3A4CHRM1
SCHEMBL7875531 0.75 CYP3A4 (0.46) ALDH1A1TTRBACE1CYP3A4CHRM1
SCHEMBL1655127 0.73 BACE1 (0.47) ALDH1A1TTRBACE1CYP3A4CHRM1
SCHEMBL18388076 0.73 ACHE (0.40) ALDH1A1TTRACHE
SCHEMBL2261818 0.73 TTR (0.56) TTRGABRA1GABRB2
SCHEMBL16532790 0.71 CYP3A4 (0.42) ALDH1A1TTRBACE1CYP3A4CHRM1
SCHEMBL13099334 0.69 CHEK1 (0.64) ALDH1A1TTRCYP3A4ALOX15ALB
SCHEMBL13096681 0.69 CHEK1 (0.48) ALDH1A1TTRCYP3A4ALOX15ALB
SCHEMBL2321509 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140212575-A1 Novel Self-Assembling Nanocomposite Structures and Methods of Preparing Same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140212575-A1 Novel Self-Assembling Nanocomposite Structures and Methods of Preparing Same CACYBP, CAPG, NCBP2 ALDH1A1 2357/4885TTR 1251/4885BACE1 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.